100% Same
Salt CompositionEffectivenessStrength
Top Branded
Substitute
Salt Composition in bothRivastigmine 1.5mg
You Searched
Rivera 1.5mg Capsule
Zydus Cadila
₹44.8
Our Recommendation
Rivazin 1.5mg Capsule 10s
10+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Treatment of Dementia in Alzheimer's disease / Treatment of Dementia Associated with Parkinson's disease
Customers also bought
More About Rivera
Benefits
In Treatment of Dementia in Alzheimer's disease In people with Alzheimer?s disease, certain nerve cells die in the brain. This results in lower levels of a chemical called acetylcholine which helps nerve cells to communicate with each other. This leads to symptoms of dementia such as memory loss, confusion, disorientation, problems with speech and language, and personality changes. Rivera 1.5mg Capsule increases the amount of acetylcholine and helps brain cells to communicate. It can, therefore, improve some of the symptoms such as memory, awareness, and the ability to carry out daily functions for a time. However, it is not a cure. You should use the medicine exactly as prescribed. It can take several weeks for your symptoms to improve; so keep using the medicine even if you do not think it is working. In Treatment of Dementia Associated with Parkinson's disease Dementia in Parkinson?s disease refers to problems in memory and thinking that are advanced, interfering with daily activities and quality of life. Rivera 1.5mg Capsule helps in managing these symptoms in a safe manner that can be used for a long term. This will make it easier for you to carry out your daily activities and improve your quality of life.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Rivera 1.5mg Capsule is to be taken with food.
How it works
Memory loss in Alzheimer?s disease occurs due to disturbances of signal transmission in the brain. Rivera 1.5mg Capsule is a cholinesterase inhibitor. It works by increasing the levels of a chemical messenger (acetylcholine) involved in transmmission of nerve signals. This improves memory and thinking.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Rivera 1.5mg Capsule . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Safe when prescribed by an expert: Rivera 1.5mg Capsule is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Seek medical advice from your doctor: Rivera 1.5mg Capsule is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Not Safe: Rivera 1.5mg Capsule may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Safe when prescribed by an expert: Rivera 1.5mg Capsule is safe to use in patients with kidney disease. No dose adjustment of Rivera 1.5mg Capsule is recommended. However, inform your doctor if you have underlying kidney diseases as close monitoring is advised while you are taking this medicine.
Safe when prescribed by an expert: Rivera 1.5mg Capsule is safe to use in patients with liver disease. No dose adjustment of Rivera 1.5mg Capsule is recommended. However, inform your doctor if you have an underlying liver disease as close monitoring is advised while you are taking this medicine.
What if I forget to take it?
If you forget a dose of Rivera 1.5mg Capsule , simply continue with your regular schedule and do not take a double dose.
Manufacturer Address
Zydus Tower, Satellite Cross Roads,Ahmedabad ‚ 380015 Gujarat, India.
References
Stahl SM, editor. Rivastigmine. In: Stahl's Essential Pschopharmacology: Prescriber's Guide. 5th ed. New York, New York: Cambridge University Press; 2014. pp. 603-607
Katzung BG. Special Aspects of Geriatric Pharmacology. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 1041
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 1229
Rivastigmine tartrate. East Hanover, New Jersey: Novartis Pharmaceuticals Corporation; 2000 (24 Jan. 2019)
Rivastigmine. Camberley, Surrey: Sandoz Limited; 2014 (22 Mar. 2019)
Central Drugs Standard Control Organisation (CDSCO) (22 Mar. 2019)
Müller T. Rivastigmine in the treatment of patients with Alzheimer's disease. Neuropsychiatr Dis Treat. 2007 Apr;3(2):211-8 (20 Feb. 2024)
Rivastigmine transdermal system (20 Feb. 2024)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
